USD 13.09
(-3.96%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 87.79 Million USD | -34.28% |
2022 | 133.59 Million USD | 15.13% |
2021 | 116.04 Million USD | 135.2% |
2020 | 49.33 Million USD | 26.0% |
2019 | 39.15 Million USD | 119.97% |
2018 | 17.8 Million USD | 13.67% |
2017 | 15.66 Million USD | 9.54% |
2016 | 14.29 Million USD | 47.46% |
2015 | 9.69 Million USD | 41.76% |
2014 | 6.83 Million USD | -2.56% |
2013 | 7.01 Million USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 78.1 Million USD | -0.58% |
2024 Q1 | 78.56 Million USD | -10.51% |
2024 Q3 | 79.82 Million USD | 2.2% |
2023 Q3 | 110.47 Million USD | -3.9% |
2023 Q2 | 114.96 Million USD | -3.67% |
2023 Q4 | 87.79 Million USD | -20.53% |
2023 Q1 | 119.33 Million USD | -10.67% |
2023 FY | 87.79 Million USD | -34.28% |
2022 Q2 | 123.18 Million USD | 4.37% |
2022 Q4 | 133.59 Million USD | -0.4% |
2022 FY | 133.59 Million USD | 15.13% |
2022 Q1 | 118.03 Million USD | 1.72% |
2022 Q3 | 134.12 Million USD | 8.88% |
2021 Q4 | 116.04 Million USD | -1.06% |
2021 Q3 | 117.28 Million USD | 139.78% |
2021 Q1 | 50.15 Million USD | 1.66% |
2021 Q2 | 48.91 Million USD | -2.47% |
2021 FY | 116.04 Million USD | 135.2% |
2020 FY | 49.33 Million USD | 26.0% |
2020 Q4 | 49.33 Million USD | 1.45% |
2020 Q3 | 48.63 Million USD | 27.49% |
2020 Q2 | 38.14 Million USD | -10.2% |
2020 Q1 | 42.47 Million USD | 8.48% |
2019 Q1 | 21.51 Million USD | 20.88% |
2019 Q3 | 39.8 Million USD | 74.38% |
2019 Q2 | 22.82 Million USD | 6.09% |
2019 FY | 39.15 Million USD | 119.97% |
2019 Q4 | 39.15 Million USD | -1.64% |
2018 FY | 17.8 Million USD | 13.67% |
2018 Q1 | 13.91 Million USD | -11.17% |
2018 Q2 | 13.96 Million USD | 0.38% |
2018 Q3 | 18.31 Million USD | 31.17% |
2018 Q4 | 17.8 Million USD | -2.82% |
2017 Q2 | 11.7 Million USD | 0.2% |
2017 Q1 | 11.67 Million USD | -18.32% |
2017 FY | 15.66 Million USD | 9.54% |
2017 Q4 | 15.66 Million USD | 7.19% |
2017 Q3 | 14.6 Million USD | 24.86% |
2016 Q1 | 14.56 Million USD | 50.2% |
2016 FY | 14.29 Million USD | 47.46% |
2016 Q4 | 14.29 Million USD | 31.68% |
2016 Q3 | 10.85 Million USD | 33.71% |
2016 Q2 | 8.12 Million USD | -44.24% |
2015 Q3 | 7.5 Million USD | 30.1% |
2015 Q2 | 5.77 Million USD | 0.0% |
2015 FY | 9.69 Million USD | 41.76% |
2015 Q1 | - USD | -100.0% |
2015 Q4 | 9.69 Million USD | 29.15% |
2014 Q4 | 6.83 Million USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 FY | 6.83 Million USD | -2.56% |
2013 FY | 7.01 Million USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Accelerate Diagnostics, Inc. | 51.25 Million USD | -71.296% |
BrainsWay Ltd. | 15.31 Million USD | -473.305% |
Cerus Corporation | 144.3 Million USD | 39.159% |
Envoy Medical, Inc. | 9.4 Million USD | -833.801% |
electroCore, Inc. | 8.94 Million USD | -881.509% |
Helius Medical Technologies, Inc. | 5.34 Million USD | -1543.504% |
IceCure Medical Ltd | 4.24 Million USD | -1967.247% |
Inogen, Inc. | 121.38 Million USD | 27.67% |
OrthoPediatrics Corp. | 72.56 Million USD | -20.996% |
Lucid Diagnostics Inc. | 29.58 Million USD | -196.799% |
Monogram Orthopaedics, Inc. | 3.18 Million USD | -2659.195% |
MaxCyte, Inc. | 36.1 Million USD | -143.155% |
NeuroOne Medical Technologies Corporation | 1.84 Million USD | -4651.097% |
Nexalin Technology, Inc. | 425.28 Thousand USD | -20544.233% |
Orthofix Medical Inc. | 326.58 Million USD | 73.117% |
PAVmed Inc | 57.13 Million USD | -53.659% |
Rapid Micro Biosystems, Inc. | 25.46 Million USD | -244.798% |
RxSight, Inc. | 22.18 Million USD | -295.691% |
Sight Sciences, Inc. | 46.43 Million USD | -89.069% |
SI-BONE, Inc. | 61.05 Million USD | -43.81% |
TELA Bio, Inc. | 59.16 Million USD | -48.387% |
Treace Medical Concepts, Inc. | 113.96 Million USD | 22.965% |
Vivos Therapeutics, Inc. | 10.31 Million USD | -750.819% |
Acutus Medical, Inc. | 54.83 Million USD | -60.098% |
Talis Biomedical Corporation | 29.22 Million USD | -200.424% |
Spectral AI, Inc. | 12.4 Million USD | -607.975% |
Nano-X Imaging Ltd. | 23.13 Million USD | -279.511% |
CVRx, Inc. | 39.28 Million USD | -123.502% |
DIH Holding US, Inc. Warrants | 11.95 Million USD | -634.198% |
PetVivo Holdings, Inc. | 2.42 Million USD | -3514.045% |
Bioventus Inc. | 589.79 Million USD | 85.114% |
Venus Concept Inc. | 107.1 Million USD | 18.027% |
TriSalus Life Sciences, Inc. | 51.66 Million USD | -69.94% |
LivaNova PLC | 1.15 Billion USD | 92.378% |
908 Devices Inc. | 37.49 Million USD | -134.185% |
Alphatec Holdings, Inc. | 703.48 Million USD | 87.52% |
Nemaura Medical Inc. | 26.37 Million USD | -232.845% |
NeuroPace, Inc. | 86.99 Million USD | -0.918% |
LENSAR, Inc. | 22.4 Million USD | -291.789% |
Apyx Medical Corporation | 52.31 Million USD | -67.812% |
Cutera, Inc. | 518.12 Million USD | 83.055% |
STRATA Skin Sciences, Inc. | 29.32 Million USD | -199.359% |
BioSig Technologies, Inc. | 4.68 Million USD | -1773.981% |
Anika Therapeutics, Inc. | 58.36 Million USD | -50.421% |
ClearPoint Neuro, Inc. | 21.48 Million USD | -308.582% |
Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 95.999% |
Axonics, Inc. | 82.35 Million USD | -6.602% |
Outset Medical, Inc. | 190.91 Million USD | 54.013% |
IRIDEX Corporation | 24.91 Million USD | -252.396% |
PROCEPT BioRobotics Corporation | 123.96 Million USD | 29.177% |
IRadimed Corporation | 20.73 Million USD | -323.4% |
Tivic Health Systems, Inc. | 1.67 Million USD | -5144.683% |
INVO Bioscience, Inc. | 19.99 Million USD | -339.091% |
Telesis Bio, Inc. | 40.87 Million USD | -114.802% |
Viemed Healthcare, Inc. | 40.79 Million USD | -115.238% |
Varex Imaging Corporation | 668.6 Million USD | 86.869% |
Quipt Home Medical Corp. | 136.29 Million USD | 35.583% |
Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -2357.895% |
Pulmonx Corporation | 60.63 Million USD | -44.792% |
Dynatronics Corporation | 11.78 Million USD | -645.29% |
Modular Medical, Inc. | 2.27 Million USD | -3764.261% |
ReShape Lifesciences Inc. | 4.06 Million USD | -2060.335% |
Semler Scientific, Inc. | 6.27 Million USD | -1300.255% |
InMode Ltd. | 75.91 Million USD | -15.652% |
Bruker Corporation | 2.83 Billion USD | 96.905% |
Cytosorbents Corporation | 29.98 Million USD | -192.795% |
DexCom, Inc. | 4.19 Billion USD | 97.908% |
Align Technology, Inc. | 2.45 Billion USD | 96.421% |
Viveve Medical, Inc. | 10.84 Million USD | -709.404% |
ZimVie Inc. | 795.85 Million USD | 88.968% |
Movano Inc. | 5.97 Million USD | -1370.127% |
Cytek Biosciences, Inc. | 104.6 Million USD | 16.069% |
Nexalin Technology, Inc. | 425.28 Thousand USD | -20544.233% |
DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -634.198% |
Tandem Diabetes Care, Inc. | 639.02 Million USD | 86.261% |
Profound Medical Corp. | 12.66 Million USD | -593.17% |
Insulet Corporation | 1.85 Billion USD | 95.268% |
enVVeno Medical Corporation | 2.43 Million USD | -3505.585% |
Surmodics, Inc. | 65.82 Million USD | -33.382% |
iCAD, Inc. | 8 Million USD | -997.313% |
Nuwellis, Inc. | 6.78 Million USD | -1194.926% |
Biotricity, Inc. | 35.91 Million USD | -144.425% |
iRhythm Technologies, Inc. | 223.04 Million USD | 60.638% |
Aethlon Medical, Inc. | 2.47 Million USD | -3440.661% |
InspireMD, Inc. | 8.14 Million USD | -978.31% |
PAVmed Inc. | 57.13 Million USD | -53.659% |
BIOLASE, Inc. | 35.34 Million USD | -148.376% |
Beyond Air, Inc. | 29.77 Million USD | -194.865% |
FONAR Corporation | 57.45 Million USD | -52.801% |
AxoGen, Inc. | 101.16 Million USD | 13.212% |
Vivani Medical, Inc. | 25.03 Million USD | -250.679% |
Inari Medical, Inc. | 209.32 Million USD | 58.058% |
UFP Technologies, Inc. | 118.04 Million USD | 25.625% |
QT Imaging Holdings, Inc. | 12.69 Million USD | -591.825% |
Heart Test Laboratories, Inc. | 2.18 Million USD | -3916.631% |
Tenon Medical, Inc. | 5.56 Million USD | -1477.079% |
Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -4835.132% |
Co-Diagnostics, Inc. | 17.63 Million USD | -397.876% |
AdaptHealth Corp. | 3.15 Billion USD | 97.216% |
Sintx Technologies, Inc. | 6.59 Million USD | -1231.655% |
NanoVibronix, Inc. | 2.68 Million USD | -3168.652% |
Quanterix Corporation | 78.08 Million USD | -12.438% |
Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -2357.895% |
Sensus Healthcare, Inc. | 4.88 Million USD | -1697.257% |
Pacific Biosciences of California, Inc. | 1.04 Billion USD | 91.596% |
TransMedics Group, Inc. | 568.84 Million USD | 84.566% |
ReWalk Robotics Ltd. | 16.68 Million USD | -426.292% |
NeuroMetrix, Inc. | 1.33 Million USD | -6485.734% |
Hyperfine, Inc. | 9.8 Million USD | -795.878% |
Establishment Labs Holdings Inc. | 250.24 Million USD | 64.916% |
Biomerica, Inc. | 2.66 Million USD | -3196.883% |
Bone Biologics Corporation | 831.4 Thousand USD | -10459.994% |
AVITA Medical, Inc. | 19.86 Million USD | -341.954% |
Bluejay Diagnostics, Inc. | 1.97 Million USD | -4348.333% |
Silk Road Medical, Inc | 114.15 Million USD | 23.093% |